The Bcl-2 repertoire of mesothelioma spheroids underlies acquired apoptotic multicellular resistance
about
AlgiMatrix™ based 3D cell culture system as an in-vitro tumor model for anticancer studiesApoptotic agentsVariation in drug sensitivity of malignant mesothelioma cell lines with substantial effects of selenite and bortezomib, highlights need for individualized therapyVorinostat eliminates multicellular resistance of mesothelioma 3D spheroids via restoration of Noxa expressionAutophagy Correlates with the Therapeutic Responsiveness of Malignant Pleural Mesothelioma in 3D Models.Analysis of Gene Expression in 3D Spheroids Highlights a Survival Role for ASS1 in Mesothelioma.Unlocking Pandora's box: personalising cancer cell death in non-small cell lung cancer.Inhibition of autophagy sensitizes malignant pleural mesothelioma cells to dual PI3K/mTOR inhibitorsA novel sulindac derivative inhibits lung adenocarcinoma cell growth through suppression of Akt/mTOR signaling and induction of autophagyA catalogue of treatment and technologies for malignant pleural mesothelioma.PDK1 and SGK3 Contribute to the Growth of BRAF-Mutant Melanomas and Are Potential Therapeutic Targets.A microfluidic platform for chemoresistive testing of multicellular pleural cancer spheroids.The distribution and retention of paclitaxel and doxorubicin in multicellular layer cultures.Understanding sensitivity to BH3 mimetics: ABT-737 as a case study to foresee the complexities of personalized medicine.Analysis of apoptosis methods recently used in Cancer Research and Cell Death & Disease publications.Metabolic profiling of human CD4+ cells following treatment with methotrexate and anti-TNF-α infliximab.Proteasome stress sensitizes malignant pleural mesothelioma cells to bortezomib-induced apoptosis.
P2860
Q21089821-803E8D6C-CED3-4203-9427-9010D91C8D94Q27016160-F42FD2DC-F1EC-42A1-A588-960D959C4C4EQ28534042-6EE4EAA5-11F6-480F-BB3E-3CD5F2DBA41DQ34541123-3A458A7C-0B80-43AE-A97A-FBF13BC94ED8Q35748646-9C6A312B-3793-475F-85C4-8226BED0764DQ35959234-FCE27970-9BAC-4E3E-8381-ABFBC10A676BQ36173303-1CAA33AD-A9A0-4D2E-B95A-00511E824AAAQ36346942-071C84A6-C796-48DC-BD88-0E580F4BAA3FQ36836915-85B0E173-5E1D-4501-991A-5B776C40CEF7Q38760623-B7401CF0-C7F1-486F-A7C6-411607EB5B68Q38906407-B3041F34-7364-45CC-A931-1603E66EB432Q39027283-82E8BCD9-29A3-4788-95EF-408147D3F245Q39408049-E006559D-22A8-4063-9671-1C0351F93E2DQ42117299-26ADC8CF-1056-47E3-9E5C-BFA5BB1DE097Q42632659-A814E0F3-0E49-421E-BF79-15506213B068Q42770446-C8259E9A-EB4D-48C7-984A-A768C99F406DQ47096168-6830003B-A2A0-486A-BCAB-9F8B2BB69429
P2860
The Bcl-2 repertoire of mesothelioma spheroids underlies acquired apoptotic multicellular resistance
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The Bcl-2 repertoire of mesoth ...... totic multicellular resistance
@en
type
label
The Bcl-2 repertoire of mesoth ...... totic multicellular resistance
@en
prefLabel
The Bcl-2 repertoire of mesoth ...... totic multicellular resistance
@en
P2093
P2860
P356
P1476
The Bcl-2 repertoire of mesoth ...... totic multicellular resistance
@en
P2093
A D Chacko
D A Fennell
D J Sugarbaker
D M Jablons
L M Coussens
N Kolhatkar
V C Broaddus
P2860
P356
10.1038/CDDIS.2011.58
P50
P577
2011-06-23T00:00:00Z